Kenta Biotech is dedicated to discovering and developing groundbreaking, fully human monoclonal antibodies for the treatment of severe infectious diseases. To achieve this, they employ their exclusive MabIgX technology platform, which allows for the creation of a new category of fully human monoclonal antibodies with enhanced safety and efficacy profiles.

Disease Domain	Count

Infectious Diseases	2

Top 5 Drug Type	Count

Monoclonal antibody	2

Top 5 Target	Count

alpha-toxin(Alpha-hemolysin)	1

Corporation Tree

Boost your research with our corporation tree data.

view full example data

Pipeline

Pipeline Snapshot as of 12 Jun 2026

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Phase 1

Phase 3

Other

Current Projects

Drug(Targets)	Indications	Global Highest Phase

Tosatoxumab ( alpha-toxin )	Healthcare-Associated Pneumonia More	Phase 3
Anti-infective monoclonal antibody(Kenta Biotech AG)	Cystic Fibrosis More	Phase 1
Panobacumab ( LPS )	Hospital-acquired pneumonia More	Pending
KBSA-302	Staphylococcal Infections More	Pending

Deal

Boost your decision using our deal data.

view full example data

Translational Medicine

Boost your research with our translational medicine data.

view full example data

Profit

Explore the financial positions of over 360K organizations with Synapse.

view full example data

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.

view full example data

Investment

Gain insights on the latest company investments from start-ups to established corporations.

view full example data

Financing

Unearth financing trends to validate and advance investment opportunities.

view full example data

AI Agents Built for Biopharma Breakthroughs

Accelerate discovery. Empower decisions. Transform outcomes.

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Start your data trial now!

Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.

Bio

Bio Sequences Search & Analysis

Chemical

Chemical Structures Search & Analysis